1. Home
  2. ENR vs REPL Comparison

ENR vs REPL Comparison

Compare ENR & REPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Energizer Holdings Inc.

ENR

Energizer Holdings Inc.

HOLD

Current Price

$22.22

Market Cap

1.4B

Sector

Miscellaneous

ML Signal

HOLD

Logo Replimune Group Inc.

REPL

Replimune Group Inc.

HOLD

Current Price

$12.52

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENR
REPL
Founded
2015
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.3B
IPO Year
2015
2018

Fundamental Metrics

Financial Performance
Metric
ENR
REPL
Price
$22.22
$12.52
Analyst Decision
Buy
Hold
Analyst Count
7
9
Target Price
★ $23.14
$5.67
AVG Volume (30 Days)
833.9K
★ 1.8M
Earning Date
05-05-2026
05-21-2026
Dividend Yield
★ 6.48%
N/A
EPS Growth
★ 538.46
N/A
EPS
★ 3.32
N/A
Revenue
★ $2,952,700,000.00
N/A
Revenue This Year
$3.87
N/A
Revenue Next Year
$0.85
N/A
P/E Ratio
$6.69
★ N/A
Revenue Growth
★ 2.28
N/A
52 Week Low
$15.75
$1.50
52 Week High
$26.14
$16.33

Technical Indicators

Market Signals
Indicator
ENR
REPL
Relative Strength Index (RSI) 56.99 41.23
Support Level $19.47 $12.40
Resistance Level $22.18 $16.02
Average True Range (ATR) 0.70 0.73
MACD 0.17 -0.22
Stochastic Oscillator 81.41 16.61

Price Performance

Historical Comparison
ENR
REPL

About ENR Energizer Holdings Inc.

Energizer Holdings Inc. manufactures and distributes household batteries, specialty batteries, and lighting products. The company offers batteries using lithium, alkaline, carbon zinc, nickel metal hydride, zinc air, and silver oxide technologies, sold under the Energizer, Rayovac, Varta, and Eveready brands across performance and premium price segments. It also provides auto care products in the appearance, fragrance, performance, and air conditioning recharge categories. Energizer operates through two geographical segments, the United States and International, with the majority of its revenue generated in the United States. It has two product segments: Batteries and Lights and Auto Care, with the Batteries and Lights segment contributing the majority of its revenue.

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company committed to applying its expertise in the field of oncolytic immunotherapy to transform the lives of cancer patients through novel oncolytic immunotherapies. Its proprietary oncolytic immunotherapy product candidates are designed and intended to maximally activate the immune system against cancer. Oncolytic immunotherapy is an emerging drug class. The proprietary RPx platform is based on a novel, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added that are intended to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. It operates in single segment of developing oncolytic immunotherapies for the treatment of cancer.

Share on Social Networks: